News about

U.S. IPO market on track for best year since 2007

Mon, 13 May 2013 07:49:46 -0400

Firms have raised $16.8 billion through IPOs so far this year, and last week was the busiest since December 2007.

Zoetis Q1 Profit and Revenue Rise, Beating Estimates (ZTS)

Tue, 30 Apr 2013 10:53:23 -0400

Animal health company Zoetis Inc. (ZTS), a publicly traded subsidiary of Pfizer (PFE), reported early on Tuesday a 26% increase in first quarter profits on 4% higher revenues. Results were able to top Wall Street estimates. The Madison, New Jersey-based company posted a first quarter net income of $140 million, or 28 cents per share, [...]

BMO Capital Markets Reiterates Underperform Rating, $30 PT on Zoetis on Avian Flu Scare

Fri, 05 Apr 2013 13:26:57 -0400

In a report published Friday, BMO Capital Markets analyst Alex Arfaei reiterated an Underperform rating and $30.00 price target on Zoetis (NYSE: ZTS).

In the report, Arfaei noted, “Shares of Zoetis are weak today in part related to the 14 human cases of the H7N9 virus, an unusual strain

Benzinga's Top Initiations

Thu, 21 Mar 2013 07:52:47 -0400

Analysts at Citigroup initiated coverage on shares of Zoetis (NYSE: ZTS) with a “buy” rating. The target price range for Zoetis is set to $38. Zoetis' shares closed at $33.51 yesterday.

Oppenheimer initiated coverage on shares of GenCorp (NYSE: GY) with an “outperform” rating. The target

Barron's Recap (3/16/13): A New Way to Play Emerging Markets

Sat, 16 Mar 2013 11:46:51 -0400

This weekend in Barron's online: a more sophisticated strategy for investing in emerging markets, an ETF special report, and the prospects for The Pantry and Globe Specialty Metals.

Cover Story

"Emerging Markets: The Next Wave" by Reshma Kapadia.

A more complicated global economy calls for a more sophisticated strategy for investing

7 Analysts Initiate Coverage on Zoetis; Who to Believe?

Wed, 13 Mar 2013 11:47:42 -0400

Zoetis (NYSE: ZTS), a company researching animal vaccines and treatments that was formerly owned by Pfizer (NYSE: PFE), received a long list of ratings initiations this morning.

The breakdown of the ratings can be split into two sections: Buy and Hold equivalents.

First the Hold sentiments:

UPDATE: Hilliard Lyons Initiates Zoetis at Neutral on Valuation

Tue, 12 Mar 2013 11:00:40 -0400

Hilliard Lyons initiated coverage on Zoetis (NYSE: ZTS) with a Neutral rating.

Hilliard Lyons commented, "ZTS is the first major participant in the global animal health business available to those interested in investing in the sector, which might explain some of the strong initial interest. ZTS shares rose nearly

IPOs – Of Real Companies With Real Profits – Follow Market’s Rise

Fri, 08 Feb 2013 10:59:58 -0500

Stocks to watch Monday: Gilead, Simon Property

Sun, 03 Feb 2013 08:01:04 -0500

Monday brings earnings reports with Gilead Sciences, Simon Property Group, Anadarko Petroleum and Yum Brands.

Mid-Day Market Update: CARBO Ceramics Rising, Keyx Continues to Give Back Gains

Fri, 01 Feb 2013 14:15:38 -0500

Mid-way through trading Friday, the Dow traded up 0.85 percent to 13,995.24 while the NASDAQ rose 1.20 percent to 3,179.75. The S&P also rose, increasing 0.99 percent to 1,512.54.

Top Headline Making headlines Friday morning was the unemployment figure for the month of January. Coming in at 7.9 percent, it rose from

Zoetis IPO rings up 20% gains in market debut

Fri, 01 Feb 2013 12:21:19 -0500

The debut of the Pfizer spinoff rings up big gains, the biggest since last year’s Facebook.

24/7 Wall St. Closing Bell — February 1, 2013: Markets Stronger on Economic Data (VZ, MA, EPD, STZ, UPS, BYI, GDOT, WYNN, CVX, XOM, MAT, MRK, NOV, TSN, CYOU, GCI, HUM, GOLD, RCL, SPG, CLX, ZTS, KERX,

Fri, 01 Feb 2013 11:08:00 -0500

DailyFinance.com: U.S. equity markets opened higher this morning on the heels of a solid report on U.S. nonfarm payrolls, which rose less than expected but on top of a large upward revision for December (more coverage here). In Europe, PMI data was released and, with ... Read more

Pfizer Offers Statement on Zoetis IPO

Fri, 01 Feb 2013 09:58:02 -0500

Pfizer Inc. (NYSE: PFE) today announced that its former animal health business unit, now a standalone company named Zoetis (NYSE: ZTS), began trading on the New York Stock Exchange under the ticker symbol “ZTS.”

“This is a proud moment for all Zoetis and Pfizer employees,” said Ian Read, chairman and

Animal Health Firm IPO Soars (ZTS)

Fri, 01 Feb 2013 05:23:00 -0500

DailyFinance.com: Zoetis Inc. (NYSE: ZTS), a spin-off of the animal health business of Pfizer Inc. (NYSE: PFE), held its initial public offering this morning. The company offered 86.1 million shares at $26 a share, $1.00 above the estimated range of $22 to $25. Pfizer ... Read more

Will These 2 IPOs Flourish?

Tue, 22 Jan 2013 13:19:05 -0500

It was a great day to be Norwegian Cruise Lines (NASDAQ: NCLH) on Friday. After pricing their IPO at $19 per share—up from the expected range of $16-$18, the market bid the stock up 31 percent on its first day of trading. Investors appeared to value the stock